Qin P, Moore M, Jung S, Fukazawa T, Yamasaki N, Chatterjee S
J Org Chem. 2024; 89(17):12701-12710.
PMID: 39169612
PMC: 11380578.
DOI: 10.1021/acs.joc.4c01927.
Chan D, Dykema K, Fatima M, Harvey H, Qaderi I, Burrows L
ACS Infect Dis. 2023; 9(7):1408-1423.
PMID: 37279282
PMC: 10353551.
DOI: 10.1021/acsinfecdis.3c00167.
Moore M, Qin P, Keith D, Wu Z, Jung S, Chatterjee S
J Am Chem Soc. 2023; 145(23):12837-12852.
PMID: 37278486
PMC: 10330940.
DOI: 10.1021/jacs.3c03710.
Moore M, Qin P, Keith D, Boger D
Tetrahedron. 2023; 131.
PMID: 36776940
PMC: 9913888.
DOI: 10.1016/j.tet.2022.133211.
Talukder N, Feezel A, Lankford J
J Med Case Rep. 2022; 16(1):74.
PMID: 35183255
PMC: 8858032.
DOI: 10.1186/s13256-022-03299-6.
Mechanisms of gram-positive vancomycin resistance (Review).
Selim S
Biomed Rep. 2021; 16(1):7.
PMID: 34938536
PMC: 8686198.
DOI: 10.3892/br.2021.1490.
Mapping and Exploiting the Promiscuity of OxyB toward the Biocatalytic Production of Vancomycin Aglycone Variants.
Forneris C, Nguy A, Seyedsayamdost M
ACS Catal. 2021; 10(16):9287-9298.
PMID: 34422446
PMC: 8378672.
DOI: 10.1021/acscatal.0c01719.
Prevention the formation of biofilm on orthopedic implants by melittin thin layer on chitosan/bioactive glass/vancomycin coatings.
Zarghami V, Ghorbani M, Pooshang Bagheri K, Shokrgozar M
J Mater Sci Mater Med. 2021; 32(7):75.
PMID: 34156547
PMC: 8219550.
DOI: 10.1007/s10856-021-06551-5.
Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
Wu Z, Boger D
Acc Chem Res. 2020; 53(11):2587-2599.
PMID: 33138354
PMC: 7674238.
DOI: 10.1021/acs.accounts.0c00569.
Methicillin-resistant : epidemiology and antimicrobial susceptibility experiences from the University Hospital 'Luigi Vanvitelli' of Naples.
Pignataro D, Foglia F, Della Rocca M, Melardo C, Santella B, Folliero V
Pathog Glob Health. 2020; 114(8):451-456.
PMID: 33012280
PMC: 7831655.
DOI: 10.1080/20477724.2020.1827197.
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.
Shariati A, Dadashi M, Moghadam M, van Belkum A, Yaslianifard S, Darban-Sarokhalil D
Sci Rep. 2020; 10(1):12689.
PMID: 32728110
PMC: 7391782.
DOI: 10.1038/s41598-020-69058-z.
Vancomycin C-Terminus Guanidine Modifications and Further Insights into an Added Mechanism of Action Imparted by a Peripheral Structural Modification.
Wu Z, Cameron M, Boger D
ACS Infect Dis. 2020; 6(8):2169-2180.
PMID: 32598127
PMC: 7429263.
DOI: 10.1021/acsinfecdis.0c00258.
The anti-MRSA compound 3-O-alpha-L-(2″,3″-di-p-coumaroyl)rhamnoside (KCR) inhibits protein synthesis in Staphylococcus aureus.
Carruthers N, Stemmer P, Media J, Swartz K, Wang X, Aube N
J Proteomics. 2019; 210:103539.
PMID: 31629958
PMC: 7014561.
DOI: 10.1016/j.jprot.2019.103539.
Exploration of the site-specific nature and generalizability of a trimethylammonium salt modification on vancomycin: A-ring derivatives.
Wu Z, Boger D
Tetrahedron. 2019; 75(24):3160-3165.
PMID: 31327878
PMC: 6640857.
DOI: 10.1016/j.tet.2019.02.008.
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea.
Park J, Lee H, Kim J, Kim B
Sci Rep. 2019; 9(1):6236.
PMID: 30996231
PMC: 6470132.
DOI: 10.1038/s41598-019-42307-6.
N-Terminus Alkylation of Vancomycin: Ligand Binding Affinity, Antimicrobial Activity, and Site-Specific Nature of Quaternary Trimethylammonium Salt Modification.
Wu Z, Isley N, Boger D
ACS Infect Dis. 2018; 4(10):1468-1474.
PMID: 30067012
PMC: 6200594.
DOI: 10.1021/acsinfecdis.8b00152.
Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, Iran.
Shekarabi M, Hajikhani B, Chirani A, Fazeli M, Goudarzi M
PLoS One. 2017; 12(8):e0183607.
PMID: 28854219
PMC: 5576738.
DOI: 10.1371/journal.pone.0183607.
Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues.
Okano A, Isley N, Boger D
Chem Rev. 2017; 117(18):11952-11993.
PMID: 28437097
PMC: 5617763.
DOI: 10.1021/acs.chemrev.6b00820.
Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?.
Ruiz-Ramos J, Vidal-Cortes P, Diaz-Lamas A, Reig-Valero R, Roche-Campo F, Del Valle-Ortiz M
Eur J Clin Microbiol Infect Dis. 2017; 36(9):1569-1575.
PMID: 28378244
DOI: 10.1007/s10096-017-2970-3.
Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance.
Zeng D, Debabov D, Hartsell T, Cano R, Adams S, Schuyler J
Cold Spring Harb Perspect Med. 2016; 6(12).
PMID: 27663982
PMC: 5131748.
DOI: 10.1101/cshperspect.a026989.